|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.890 EUR | +0.53% |
|
-1.05% | +32.67% |
| 05-28 | Sopharma AD Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-20 | Sopharma AD Reports Sales Revenue Results for the Month and Year to Date Ended March 2026 | CI |
| Market Cap | 1.91B 1.15B 993M 915M 857M 1.61B 109B 1.63B 10.81B 4.21B 53.2B 4.32B 4.22B 184B | P/E Ratio 2024 |
12.3x | P/E Ratio 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.46B 1.48B 1.27B 1.17B 1.1B 2.06B 140B 2.09B 13.86B 5.4B 68.24B 5.54B 5.42B 236B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 03:09am | Sopharma : Notification for sale of treasury shares as of 15 June, 2026 | PU |
| 06-10 | Sopharma : Insider information | PU |
| 06-08 | Sopharma : Insider information | PU |
| 06-08 | Sopharma : Insider information | PU |
| 06-08 | Sopharma : Insider information | PU |
| 1 day | +0.53% | ||
| 1 week | -1.05% | ||
| Current month | +0.53% | ||
| 1 month | -0.53% | ||
| 3 months | +9.25% | ||
| 6 months | +30.32% | ||
| Current year | +32.67% |
| 1 week | 1.86 |  | 1.9 |
| 1 month | 1.81 | | 1.95 |
| Current year | 1.41 | | 2 |
| 1 year | 1.1 | | 2 |
| 3 years | 0.89 | | 2 |
| 5 years | 0.57 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 2000-09-30 |
Boris Borisov
DFI | Director of Finance/CFO | - | 2001-12-31 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 2010-05-18 |
| Director/Board Member | 63 | 2010-05-18 | |
| Director/Board Member | 61 | 2011-07-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-09-29 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 20-09-29 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 20-09-28 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | -1.05% | +65.67% | +81.80% | 1.15B | |
| -0.05% | +3.57% | -10.89% | -29.26% | 15.39B | |
| +0.57% | +1.15% | -26.00% | -31.59% | 7.24B | |
| +0.13% | -1.29% | -17.93% | -13.35% | 5.73B | |
| +4.47% | +9.30% | -13.07% | -32.30% | 3.9B | |
| +0.30% | +0.16% | -35.08% | -10.36% | 3.38B | |
| -0.10% | +0.63% | -22.94% | -45.73% | 3.31B | |
| +4.44% | +7.85% | +5.59% | -41.60% | 2.89B | |
| +0.02% | +6.45% | +118.84% | - | 2.73B | |
| -0.02% | -0.87% | -22.52% | -5.60% | 2.59B | |
| Average | +1.03% | +1.86% | +4.17% | -14.22% | 4.83B | |
| Weighted average by Cap. | +0.74% | +0.99% | -7.17% | -24.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.11B 1.02B 957M 1.79B 122B 1.82B 12.08B 4.71B 59.45B 4.82B 4.72B 206B | 2.63B 1.58B 1.37B 1.26B 1.18B 2.21B 150B 2.24B 14.86B 5.79B 73.15B 5.93B 5.81B 253B |
| Net income | 77.85M 46.75M 40.38M 37.21M 34.83M 65.28M 4.44B 66.29M 439M 171M 2.16B 175M 172M 7.49B | 134M 80.19M 69.26M 63.83M 59.74M 112M 7.62B 114M 754M 294M 3.71B 301M 295M 12.85B |
| Net Debt | 444M 267M 230M 212M 199M 372M 25.36B 378M 2.51B 977M 12.34B 1B 980M 42.74B | 541M 325M 281M 259M 242M 454M 30.9B 461M 3.06B 1.19B 15.04B 1.22B 1.19B 52.08B |
Employees
5,932
Sector
Drug Retailers
Calendar
07-29 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 1.890 € | +0.53% | 12,302 |
| 26-06-11 | 1.880 € | -0.79% | 39,717 |
| 26-06-10 | 1.895 € | +0.80% | 35,295 |
| 26-06-09 | 1.880 € | +0.27% | 51,261 |
| 26-06-08 | 1.875 € | -1.83% | 53,491 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
